The American Gastroenterological Association (AGA) has released an updated clinical practice guideline on the prevention of hepatitis B virus reactivation (HBVr) in at-risk persons. The document was ...
Risk-Adapted Combined-Modality Therapy in Early-Stage Extranodal Natural Killer-/T-Cell Lymphoma: A Markov Model–Based Cost-Effectiveness Analysis This prospective observational study was conducted at ...
Among 15,942 patients (median age, 58 years [range, 16-94]; 51.4% male), hepatitis B surface antigen (HBsAg) testing was performed in 90.3%, anti-HCV in 71.7%, and anti-HIV in 64.0%. HBV infection was ...
New recommendations address advances in immunosuppressive therapies and highlight antiviral prophylaxis for high-risk ...
The American Gastroenterology Association (AGA) Institute issued new clinical practice guidelines, providing evidence-based recommendations for managing hepatitis B reactivation (HBVr) in at-risk ...
Hepatitis B virus (HBV) reactivation may occur if someone has chronic HBV, prior exposure to HBV and is undergoing treatment, or a health condition that suppresses their immune system. The hepatitis B ...
PARIS — People with HIV and resolved HBV infection who switched from tenofovir-based antiretroviral therapy (ART) to tenofovir-sparing regimens did not see clinically meaningful hepatitis B virus (HBV ...
The American Gastroenterological Association (AGA) has unveiled an updated clinical practice guideline in Gastroenterology addressing the prevention and management of hepatitis B virus reactivation ...
Please provide your email address to receive an email when new articles are posted on . AGA guidance strongly recommends antiviral prophylaxis for patients at high risk for hepatitis B reactivation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results